Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01569529 · ClinicalTrials.gov registry record
Young Adult Smoker's Treatment Demand
A clinical trial of Smoking Cessation, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- 3,070
- Enrollment target
- 1
- Study location
NCT01569529 is a study of Smoking Cessation that has completed, run by University of Illinois at Chicago. The registered enrollment target is 3,070 participants, above the 458-participant average among 188 other Smoking Cessation trials with a reported enrollment target (570% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01569529, a study of Smoking Cessation, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- 3,070 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether tailored online advertisements will drive young adult smoker's (18 to 26 years old), who are motivated to quit, to use Internet-based cessation treatment.
Conditions Studied
Interventions
- BEHAVIORAL Online advertisement
Study Locations (1)
Illinois
- Institute for Health Reseach and Policy, UIC - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,070 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01569529
The ClinicalTrials.gov registry entry for NCT01569529 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,070 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 458-participant average among 188 other Smoking Cessation trials with a reported enrollment target (570% higher). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Online advertisement is the first listed.
NCT01569529 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01569529 about?
NCT01569529 is a clinical study titled "Young Adult Smoker's Treatment Demand". The purpose of this study is to determine whether tailored online advertisements will drive young adult smoker's (18 to 26 years old), who are motivated to quit, to use Internet-based cessation treatment.
What is the current status of trial NCT01569529?
This trial is currently completed. The enrollment target is 3,070 participants. The study started on 2012-05. Estimated completion is 2012-11.
What conditions does trial NCT01569529 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT01569529?
The interventions under investigation include: Online advertisement (BEHAVIORAL).
Who is sponsoring clinical trial NCT01569529?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01569529 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
RECRUITING
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.